Immediate Impact
56 standout
Citing Papers
Cancer statistics, 2024
2024 Standout
A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy
2024 Standout
Works of Inger Persson being referenced
Safety and efficacy of the combination of pegylated interferon-α2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients
2016
Bias Of The Cox Model Hazard Ratio
2005
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Inger Persson | 38 | 207 | 4 | 57 | 49 | 25 | 428 | |
| Ruzan Avetisyan | 40 | 94 | 14 | 21 | 21 | 12 | 415 | |
| Jean-Michel Joubert | 22 | 114 | 3 | 87 | 33 | 42 | 459 | |
| Ashley F. Slagle | 25 | 74 | 10 | 12 | 14 | 24 | 410 | |
| Mark Arnold | 29 | 27 | 2 | 71 | 68 | 37 | 486 | |
| So Jung Yang | 41 | 13 | 11 | 33 | 30 | 17 | 493 | |
| Michele Fusaroli | 31 | 43 | 12 | 65 | 43 | 494 | ||
| Marci Clark | 44 | 35 | 14 | 26 | 21 | 21 | 479 | |
| Kai Yeung | 20 | 34 | 2 | 16 | 17 | 38 | 447 | |
| Joanna P. MacEwan | 26 | 65 | 43 | 22 | 53 | 373 | ||
| Wendy Smith | 75 | 35 | 6 | 35 | 5 | 18 | 415 |
All Works
Login with ORCID to disown or claim papers
Loading papers...